The effect of a polynutrient supplement on fatigue and physical activity of patients with chronic fatigue syndrome: A double-blind randomized controlled trial

QJM: An International Journal of Medicine

Volumn 95, Issue 10, 2002, Pages 677-683

  Brouwers, F M ^a   Van Der Werf, S ^a   Bleijenberg, G ^a   Van Der Zee, L ^b   Van Der Meer, J W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NUMICO RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; MINERAL; MULTIVITAMIN; PLACEBO; VITAMIN;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FATIGUE; FEMALE; HEALTH STATUS; HUMAN; MALE; NUTRIENT; OUTCOMES RESEARCH; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOM;

EID: 0036798716     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/95.10.677     Document Type: Article

References (25)

1. Reid S, Chalder T, Cleare A, Hotopf M, Wessely S. Chronic fatigue syndrome. Br Med J 2000; 320:292-6.
2. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994; 121:953-9.
3. Grant JE, Veldee MS, Buchwald D. Analysis of dietary intake and selected nutrient concentrations in patients with chronic fatigue syndrome. J Am Diet Assoc 1996; 96:383-6.
4. Heap LC, Peters TJ, Wessely S. Vitamin B status in patients with chronic fatigue syndrome. J Roy Soc Med 1999; 92:183-5.
5. Cox IM, Campbell MJ, Dowson D. Red blood cell magnesium and chronic fatigue syndrome. Lancet 1991; 337:757-60.
6. De Lorenzo F, Hargreaves J, Kakkar VV. Phosphate diabetes in patients with chronic fatigue syndrome. Postgrad Med J 1998; 74:229-32.
7. Plioplys AV, Plioplys S. Serum levels of carnitine in chronic fatigue syndrome: clinical correlates. Neuropsychobiology 1995; 32:132-8.
8. Kuratsune H, Yamaguti K, Takahashi M, Misaki H, Tagawa S, Kitani T. Acylcarnitine deficiency in chronic fatigue syndrome. Clin Infect Dis 1994; 18:(Suppl. 1)S62-7.
9. Clague JE, Edwards RH, Jackson MJ. Intravenous magnesium loading in chronic fatigue syndrome. Lancet 1992; 340:124-5.
10. Gantz NM. Magnesium and chronic fatigue. Lancet 1991; 338:66.
11. Kaslow JE, Rucker L, Onishi R. Liver extract-folic acidcyanocobalamin vs. placebo for chronic fatigue syndrome. Arch Intern Med 1989; 149:2501-3.
12. Soetekouw PMMB, Wevers RA, Vreken P, Elving LD, Janssen AJM, van der Veen Y, et al. Normal carnitine levels in patients with chronic fatigue syndrome. Netherlands J Med 2000; 57:20-4.
13. Lane RJ, Barrett MC, Woodrow D, Moss J, Fletcher R, Archard LC. Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome. J Neurol Neurosurg Psychiat 1998; 64:362-7.
14. McCully KK, Natelson BH, Iotti S, Sisto S, Leigh JS Jr. Reduced oxidative muscle metabolism in chronic fatigue syndrome. Muscle Nerve 1996; 19:621-5.
15. Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand 1990; 82:209-16.
16. Warren G, McKendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA. Acta Neurol Scand 1999; 99:112-16.
17. Plioplys AV, Plioplys S. Amantadine and L-carnitine treatment of chronic fatigue syndrome. Neuropsychobiology 1997; 35:16-23.
18. Forsyth LM, Preuss HG, MacDowell AL, Chiazze L, Jr, Birkmayer GD, Bellanti JA. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol 1999; 82:185-91.
19. Martin R-W-Y, Ogston S-A, Evans J-R. Effects of vitamin and mineral supplementation on symptoms associated with chronic fatigue syndrome with Coxsackie B antibodies. J Nutr Med 1994; 4:11-23.
20. Le Gal M, Cathebras P, Strüby K. Pharmaton capsules in the treatment of functional fatigue: a double-blind study versus placebo evaluated by a new methodology. Phytotherapy Res 1996; 10:49-53.
21. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19:787-805.
22. Jacobs HM, Luttik A, Touw Otten FW, de Melker RA. [The sickness impact profile; results of an evaluation study of the Dutch version] De 'sickness impact profile'; resultaten van een valideringsonderzoek van de Nederlandse versie. Ned Tijdschr Geneeskd 1990; 134:1950-4.
23. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994; 38:383-92.
24. Vercoulen JH, Bazelmans E, Swanink CM, Fennis JF, Galama JM, Jongen PJ, et al. Physical activity in chronic fatigue syndrome: assessment and its role in fatigue. J Psychiatr Res 1997; 31:661-73.
25. Vercoulen JH, Swanink CM, Zitman FG, Vreden SG, Hoofs MP, Fennis JF, et al. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 1996; 347:858-61.